229 related articles for article (PubMed ID: 23682778)
1. Chemopreventive and anti-cancer efficacy of silibinin against growth and progression of lung cancer.
Mateen S; Raina K; Agarwal R
Nutr Cancer; 2013; 65 Suppl 1(0 1):3-11. PubMed ID: 23682778
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells.
Mateen S; Raina K; Jain AK; Agarwal C; Chan D; Agarwal R
Epigenetics; 2012 Oct; 7(10):1161-72. PubMed ID: 22965008
[TBL] [Abstract][Full Text] [Related]
3. Silibinin synergizes with histone deacetylase and DNA methyltransferase inhibitors in upregulating E-cadherin expression together with inhibition of migration and invasion of human non-small cell lung cancer cells.
Mateen S; Raina K; Agarwal C; Chan D; Agarwal R
J Pharmacol Exp Ther; 2013 May; 345(2):206-14. PubMed ID: 23461975
[TBL] [Abstract][Full Text] [Related]
4. Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance.
Singh RP; Mallikarjuna GU; Sharma G; Dhanalakshmi S; Tyagi AK; Chan DC; Agarwal C; Agarwal R
Clin Cancer Res; 2004 Dec; 10(24):8641-7. PubMed ID: 15623648
[TBL] [Abstract][Full Text] [Related]
5. Stem cell-like ALDH(bright) cellular states in EGFR-mutant non-small cell lung cancer: a novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin.
Corominas-Faja B; Oliveras-Ferraros C; Cuyàs E; Segura-Carretero A; Joven J; Martin-Castillo B; Barrajón-Catalán E; Micol V; Bosch-Barrera J; Menendez JA
Cell Cycle; 2013 Nov; 12(21):3390-404. PubMed ID: 24047698
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer prevention by silibinin.
Singh RP; Agarwal R
Curr Cancer Drug Targets; 2004 Feb; 4(1):1-11. PubMed ID: 14965263
[TBL] [Abstract][Full Text] [Related]
7. Enhanced inhibition of lung adenocarcinoma by combinatorial treatment with indole-3-carbinol and silibinin in A/J mice.
Dagne A; Melkamu T; Schutten MM; Qian X; Upadhyaya P; Luo X; Kassie F
Carcinogenesis; 2011 Apr; 32(4):561-7. PubMed ID: 21273642
[TBL] [Abstract][Full Text] [Related]
8. Silibinin prevents lung tumorigenesis in wild-type but not in iNOS-/- mice: potential of real-time micro-CT in lung cancer chemoprevention studies.
Ramasamy K; Dwyer-Nield LD; Serkova NJ; Hasebroock KM; Tyagi A; Raina K; Singh RP; Malkinson AM; Agarwal R
Clin Cancer Res; 2011 Feb; 17(4):753-61. PubMed ID: 21148748
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention utility of silibinin and Cdk4 pathway inhibition in Apc(-/+) mice.
Karim BO; Rhee KJ; Liu G; Zheng D; Huso DL
BMC Cancer; 2013 Mar; 13():157. PubMed ID: 23530816
[TBL] [Abstract][Full Text] [Related]
10. Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells.
Sharma G; Singh RP; Chan DC; Agarwal R
Anticancer Res; 2003; 23(3B):2649-55. PubMed ID: 12894553
[TBL] [Abstract][Full Text] [Related]
11. STAT3-targeted treatment with silibinin overcomes the acquired resistance to crizotinib in ALK-rearranged lung cancer.
Cuyàs E; Pérez-Sánchez A; Micol V; Menendez JA; Bosch-Barrera J
Cell Cycle; 2016 Dec; 15(24):3413-3418. PubMed ID: 27753543
[TBL] [Abstract][Full Text] [Related]
12. Chemopreventive and chemotherapeutic effects of intravesical silibinin against bladder cancer by acting on mitochondria.
Zeng J; Sun Y; Wu K; Li L; Zhang G; Yang Z; Wang Z; Zhang D; Xue Y; Chen Y; Zhu G; Wang X; He D
Mol Cancer Ther; 2011 Jan; 10(1):104-16. PubMed ID: 21220495
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice.
Tyagi A; Raina K; Singh RP; Gu M; Agarwal C; Harrison G; Glode LM; Agarwal R
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3248-55. PubMed ID: 18089718
[TBL] [Abstract][Full Text] [Related]
14. Silibinin reverses drug resistance in human small-cell lung carcinoma cells.
Sadava D; Kane SE
Cancer Lett; 2013 Oct; 339(1):102-6. PubMed ID: 23879966
[TBL] [Abstract][Full Text] [Related]
15. Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulators.
Mateen S; Tyagi A; Agarwal C; Singh RP; Agarwal R
Mol Carcinog; 2010 Mar; 49(3):247-58. PubMed ID: 19908243
[TBL] [Abstract][Full Text] [Related]
16. Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells.
Cufí S; Bonavia R; Vazquez-Martin A; Corominas-Faja B; Oliveras-Ferraros C; Cuyàs E; Martin-Castillo B; Barrajón-Catalán E; Visa J; Segura-Carretero A; Bosch-Barrera J; Joven J; Micol V; Menendez JA
Food Chem Toxicol; 2013 Oct; 60():360-8. PubMed ID: 23916468
[TBL] [Abstract][Full Text] [Related]
17. Effect of silibinin on the growth and progression of primary lung tumors in mice.
Singh RP; Deep G; Chittezhath M; Kaur M; Dwyer-Nield LD; Malkinson AM; Agarwal R
J Natl Cancer Inst; 2006 Jun; 98(12):846-55. PubMed ID: 16788158
[TBL] [Abstract][Full Text] [Related]
18. Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin.
Bosch-Barrera J; Sais E; Cañete N; Marruecos J; Cuyàs E; Izquierdo A; Porta R; Haro M; Brunet J; Pedraza S; Menendez JA
Oncotarget; 2016 May; 7(22):32006-14. PubMed ID: 26959886
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3.
Tyagi A; Singh RP; Ramasamy K; Raina K; Redente EF; Dwyer-Nield LD; Radcliffe RA; Malkinson AM; Agarwal R
Cancer Prev Res (Phila); 2009 Jan; 2(1):74-83. PubMed ID: 19139021
[TBL] [Abstract][Full Text] [Related]
20. Role of AMPK signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma.
Li J; Li B; Xu WW; Chan KW; Guan XY; Qin YR; Lee NP; Chan KT; Law S; Tsao SW; Cheung AL
Expert Opin Ther Targets; 2016; 20(1):7-18. PubMed ID: 26568207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
